Log In
BCIQ
Print this Print this
 

FST-100

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionOphthalmic formulation of dexamethasone and povidone-iodine
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationConjunctivitis
Indication DetailsTreat viral conjunctivitis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$300.0M

$300.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/03/2015

$300.0M

$300.0M

0

Get a free BioCentury trial today